Drug
Leflunomide
Leflunomide: highest development phase Phase 1, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Leflunomide 20 mg Tablets (Geneva Pharmaceutical) NCT00946686 | Phase 1 | Rheumatoid Arthritis |
Latest
No recent events.
Follow Leflunomide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.